Table 1 Correlations between HKDC1 expression and clinicopathologic features
Characteristic | HKDC1 expression | p value | |
|---|---|---|---|
Low expression (%) | High expression (%) | ||
Age | 0.681 | ||
 > 55 | 16 (30.77%) | 36 (69.23%) |  |
 ≤ 55 | 6 (26.09%) | 17 (73.91%) |  |
Sex | 0.302 | ||
 Male | 10 (24.39%) | 31 (75.61%) |  |
 Female | 12 (35.29%) | 22 (64.71%) |  |
Tumor location | 0.428 | ||
 Left lung | 9 (25.00%) | 27 (75.00%) |  |
 Right lung | 13 (33.33%) | 26 (66.67%) |  |
Histologic differentiation | 0.003 | ||
 Well + moderate | 20 (40.82%) | 29 (59.18%) |  |
 Poor | 2 (7.69%) | 24 (92.31%) |  |
Pathological T stage | 0.627 | ||
 T1–2 | 15 (31.25%) | 33 (68.75%) |  |
 T3–4 | 7 (25.93%) | 20 (74.07%) |  |
Pathological N stage | 0.009 | ||
 N0 | 16 (43.24%) | 21 (56.76%) |  |
 N+ | 6 (15.79%) | 32 (84.21%) |  |
TNM stage | 0.843 | ||
 I + II | 13 (30.23%) | 30 (69.77%) |  |
 III + IV | 9 (28.13%) | 23 (71.87%) |  |